EUVIMEDEUVIMED entdecken
Crossref

KIF2A downregulation links amyloid-β to Tau phosphorylation in Alzheimer’s disease

Nuria Ruiz-Reig iD, Margaux Virosztek, Georges Chehade iD, Nuria Suelves iD, Nathalie Kyalu Ngoie Zola iD, Yasmine Salman iD, Olivier Schakman, Pascal Kienlen-Campard iD, Bernard Hanseeuw iD, Fadel Tissir iD

Brain · 05.05.2026 · 149 (5) · 1650-1662

DOI: 10.1093/brain/awaf382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 10.10.2025. Verfasst von Nuria Ruiz-Reig und 9 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Neurobiology Laboratory, Université Catholique de Louvain, Institute of Neuroscience, Brussels 1200, Belgium. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins, Kinesins, Amyloid beta-Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Fondation Recherche Alzheimer, FNRS, Foundation against Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microtubules are essential components of the cytoskeleton. Dysfunctions of microtubules and microtubule-associated proteins are prominent features of neurodegenerative disorders. In Alzheimer's disease, changes in microtubule composition and hyperphosphorylation of Tau are more closely related to neurodegeneration than amyloid plaque formation. However, the accumulation of amyloid beta (Aβ) species is the earliest event in Alzheimer's disease pathology and induces Tau toxicity. KIF2A is a microtubule depolarizing kinesin with important roles during cortical development. KIF2A expression is maintained in the mature brain, where it is required for neuronal survival. Here, we used a conditional approach to ablate KIF2A specifically in the adult mouse cortex and hippocampus to assess the impact of KIF2A deletion on neuronal survival and Tau phosphorylation. We found that KIF2A deficiency leads to a reduction of dendritic spine density and maturation associated with cognitive decline, followed by an increase in Tau phosphorylation through MAPK ERK1/2 upregulation. We also studied KIF2A expression in a 5xFAD mouse model and post-mortem human brain tissue. We report that Aβ accumulation alters KIF2A expression in neurons and most importantly, KIF2A protein levels are drastically reduced in patients with Alzheimer's disease, but not in patients with other primary tauopathies. Our results shed light on the relationship between Aβ accumulation, KIF2A deregulation, microtubule dysfunction and enhanced Tau phosphorylation in the context of Alzheimer's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer Diseasetau ProteinsKinesinsAmyloid beta-PeptidesAnimalsPhosphorylationHumansMiceDown-RegulationMaleNeuronsFemaleMice, TransgenicHippocampusAgedAged, 80 and overDisease Models, AnimalRepressor Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseTau phosphorylationmicrotubulesneurodegeneration

Substanzen

tau ProteinsKinesinsAmyloid beta-PeptidesKIF2A protein, mouseKIF2A protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Developmental Neurobiology Laboratory, Université Catholique de Louvain, Institute of Neuroscience, Brussels 1200, Belgium.
  • Aging and Dementia Laboratory, Université Catholique de Louvain, Institute of Neuroscience, Brussels 1200, Belgium.
  • Louvain Aging Brain Laboratory, Université Catholique de Louvain, Institute of Neuroscience, Brussels 1200, Belgium.
  • Institute of Neuroscience, Behavioral Analysis Platform, Université Catholique de Louvain, Brussels 1200, Belgium.
  • Neurology Department, Cliniques Universitaires Saint-Luc, Brussels 1200, Belgium.
  • WELBIO Department, WEL Research Institute, Wavre 1300, Belgium.

ORCID-Profile: Nuria Ruiz-Reig, Georges Chehade, Nuria Suelves, Nathalie Kyalu Ngoie Zola, Yasmine Salman, Pascal Kienlen-Campard, Bernard Hanseeuw, Fadel Tissir

Förderung

  • Fondation Recherche Alzheimer
  • FNRS
  • Foundation against Cancer
  • WelBio

Zitieren

APA

Ruiz-Reig, N., Virosztek, M., Chehade, G., Suelves, N., Kyalu Ngoie Zola, N., Salman, Y., Schakman, O., Kienlen-Campard, P., Hanseeuw, B., & Tissir, F. (2026). KIF2A downregulation links amyloid-β to Tau phosphorylation in Alzheimer’s disease. Brain, 149(5), 1650-1662. https://doi.org/10.1093/brain/awaf382

Vancouver

Ruiz-Reig N, Virosztek M, Chehade G, Suelves N, Kyalu Ngoie Zola N, Salman Y, et al. KIF2A downregulation links amyloid-β to Tau phosphorylation in Alzheimer’s disease. Brain. 2026;149(5):1650-1662. doi:10.1093/brain/awaf382

BibTeX
@article{RuizReig2026,
  author = {Ruiz-Reig, Nuria and Virosztek, Margaux and Chehade, Georges and Suelves, Nuria and Kyalu Ngoie Zola, Nathalie and Salman, Yasmine and Schakman, Olivier and Kienlen-Campard, Pascal and Hanseeuw, Bernard and Tissir, Fadel},
  title = {KIF2A downregulation links amyloid-β to Tau phosphorylation in Alzheimer’s disease},
  journal = {Brain},
  year = {2026},
  volume = {149},
  number = {5},
  pages = {1650--1662},
  doi = {10.1093/brain/awaf382}
}
Kostenlos starten →